Sie verwenden eine veraltete Version Ihres Internetbrowsers und können nicht auf die Inhalte der Seite zugreifen.
Bitte aktualisieren Sie Ihre Browserversion.
Pedraz-Petrozzi B. Clin Case Rep. Mar 2023; 11(3): e7045 Pubmed[12980]
Pedroso JL. Neurologist. Mar 2011; 17(2): 89-90 Pubmed[10587]
Peet CF. Eur J Drug Metab Pharmacokinet. Oct 2005; 30(4): 275-86 Pubmed[7985]
Peet M, Middlemiss DN, Yates RA. Pharmacocinetic interaction between propanolol and chlorpromazine in schizophrenic patients. Lancet (1980) ii, 978 [923]
Peet M, Middlemiss DN, Yates RA. Propanolol in schizophrenia II. Clinical and biochemical aspects of combining propanolol with chlorpromazine. Br J Psychiatry (1081) 138, 112-7 [924]
Peet M. Drug Saf. Feb 1995; 12(2): 146-53 Pubmed[8962]
Peeters M. Ann Pharmacother. Jun 2008; 42(6): 757-65 Pubmed[8455]
Peihua L. Open Med (Wars). Jul 2018; 13: 270-277 Pubmed, Volltext, DOI[10441]
Peitz GJ. South Med J. Apr 2009; 102(4): 411-2 Pubmed[9537]
Pejčić AV. Int J Psychiatry Clin Pract. Mar 2022; 26(1): 29-42 Pubmed[12398]
Pelet A. Am J Drug Alcohol Abuse. Jul 2011; 37(4): 264-8 Pubmed[6307]
Pelkonen O. Arch Toxicol. Oct 2008; 82(10): 667-715 Pubmed[3716]
Pelkonen O. Toxicology. Apr 2000; 144(1-3): 139-47 Pubmed[4422]
Pellene A. Clin Neuropharmacol. Nov 2015; 38(6): 252-4 Pubmed[10394]
Pelton GH. Contemp Clin Trials. Mar 2014; 37(2): 200-8 Pubmed[13119]
Pelton GH. Int J Geriatr Psychiatry. Jun 2016; 31(6): 648-55 Pubmed[9951]
Perucca E. Br J Clin Pharmacol. Aug 1977; 4(4): 485-6 Pubmed, Volltext[1596]
Perucca E. Br J Clin Pharmacol. Mar 2006; 61(3): 246-55 Pubmed, Volltext, DOI[427]
Perucca E. Clin Pharmacokinet. Jan 1982; 7(1): 57-84 Pubmed[9296]
Perucca E. Clin Pharmacokinet. Jul 1996; 31(1): 29-46 Pubmed[9350]
Perucca E. Clin Pharmacol Ther. Nov 1994; 56(5): 471-6 Pubmed[1473]
Perucca E. Epilepsia. Jan 1999; 40 Suppl 9: S7-13 Pubmed[9416]
Perucca E. Epilepsia. Jul 2008; 49(7): 1123-41 Pubmed[470]
Perucca E. Epilepsy Res. Feb 2003; 53(1-2): 47-56 Pubmed[9331]
Perucca Emilio, Johannessen Svein I, Treatment of Epilepsy: Focus on Levetiracetam. The ideal pharmacokinetic properties of an antiepileptic drug: how close does Ievetiracetam come? Epileptic Disord 2003; 5 (Supp/ 7): S17-S26 [2562]
Perugi G. Pharmacopsychiatry. Jul 2001; 34(4): 137-41 Pubmed[10387]
Pesavento TE. J Am Soc Nephrol. Jun 1996; 7(6): 831-5 Pubmed[4272]
Pescovitz MD. Am J Transplant. Oct 2009; 9(10): 2324-30 Pubmed[12742]
Pessanha TM. AIDS. Feb 2007; 21(4): 529-32 Pubmed[6388]
Peter JV. Med J Aust. Aug 2006; 185(4): 223-5 Pubmed[6513]